REMEDIES FOR SUBSTITUTION THERAPY OF THE DRY EYE SYNDROME: ANALYSIS OF THE PHARMACEUTICAL MARKET OF UKRAINE
DOI:
https://doi.org/10.11603/2312-0967.2019.4.10627Keywords:
dry eye syndrome, substitution therapy, tear fluid substitutes, marketing analysisAbstract
The aim of the work. Analysis of remedies assortment for substitution therapy of dry eye syndrome that are available on the pharmaceutical market of Ukraine.
Materials and Methods. Marketing, statistical, structural, graphic.
Results and Discussion. There are 11 drugs of the S01X A20 group – “Artificial tear fluid substitutes and other neutral drugs” and 24 registered as medical devices, including 1 multi-purpose solution (group 03. Ophthalmic and optical products), 16 ophthalmic products (group 03. Ophthalmic and optical products) and 7 solutions for washing, irrigation, treatment (group 13. Other products for treatment) among the remedies for local substitutive therapy for dry eye syndrome. An analysis of the remedies forms for substitution therapy showed that in Ukraine they are presented in four forms: eye drops, eye gel, solutions, emulsions. Assortment analysis by producing countries indicated a wide location of production capacities. The mechanism of action of these remedies is provided by the presence of active ingredients such as sodium hyaluronate, carbomer, hypromellose, carmellose, polyquad, povidone, polyvinyl alcohol, dexpanthenol with taurine, trehalose, a complex of vitamins with aminoacids, ectoin, omega-3, a combination of sodium hyaluronate with propyleneglycol and guar.
Conclusions. 35 names of remedies are used in the form of eye drops, eye gel, solutions and emulsions for substitution therapy of dry eye syndrome in Ukraine. Almost 90 % of them are produced in 3, 5, 10 or 15 ml vials. The vast majority – 80 % – of remedies for substitution therapy of dry eye syndrome are imported to Ukraine from European countries. The composition of 17 items includes sodium hyaluronate as an active substance.
Thus, it is worth to note the lack of remedies for the substitution therapy of dry eye syndrome in the form of ointments as a result of the conducted studies. In addition, attention should be paid both to the lack of remedies of this group of domestic production in general, and the limited range of active ingredients, represented only by carmellose sodium, taurine with dexpanthenol, and sodium hyaluronate.
References
Pharmaceutical encyclopedia. – Available from: https://www.pharmencyclopedia.com.ua. Ukrainian.
Craig JP, et al., TFOS DEWS II Report Executive Summary, The Ocular Surface (2017). – Available from: http://dx.doi.org/10.1016/j.jtos.2017.08.003. DOI: https://doi.org/10.1016/j.jtos.2017.08.003
Dry eye syndrome. Evidence-based clinical guidance, 2019. – Available from: http://mtd.dec.gov.ua/index.php/uk/haluzevi-standarty-ta-klinichni-nastanovy/item/421-syndrom-sukhoho-oka. Ukrainian.
Aneurin Bevan University Health Board. Dry Eye Management Guidelines (2016). – Available from: http://www.wales.nhs.uk/sites3/page.cfm?orgid=814&pid=48819.
State Register of Medicines of Ukraine (2019). – Available from: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument. Ukrainian.
State Register of Medical Equipment and Medical Devices (2019). – Available from: http://dls.gov.ua/wp-content/uploads/2018/07/%D0%A0%D0%B5%D0%B5%D0%B5%D1%81%D1%82%D1%80.pdf. Ukrainian.
Medicines Reference Compendium (2019). – Available from: https://compendium.com.ua/uk. Ukrainian.
Medicines Equivalence Reference Rx index (2019). – Available from: https://rx.ua. Ukrainian.
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
